Talby, Leila <br/><br/>
The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.  [electronic resource] 

 -  Leukemia research  Jun 2006 
 - 665-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2005.10.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthracyclines--administration & dosage<br/>Antigens, CD34--biosynthesis<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Asparaginase--administration & dosage<br/>Blast Crisis--drug therapy<br/>Burkitt Lymphoma--drug therapy<br/>Child<br/>Child, Preschool<br/>Cortisone--administration & dosage<br/>DNA-Binding Proteins--biosynthesis<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Leukemic--genetics<br/>Humans<br/>Infant<br/>Male<br/>Oligonucleotide Array Sequence Analysis--methods<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Predictive Value of Tests<br/>Proto-Oncogene Proteins c-bcr--biosynthesis<br/>Transcription Factors--biosynthesis<br/>Vincristine--administration & dosage